Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Rechercher

Affichage: 10 résultats.
    • Communication
    90yttrium Ibritumomab Tiuxetan (zevalin) Combined With Beam (z-beam) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed Or Refractory Follicular Lymphoma. a Gela Phase Ii Prospective Study
    Gisselbrecht, C. Decaudin, D. Mounier, N. Tilly, H. Ribrag, V. Sebban, C. Milpied, N. Morschhauser, F. Coiffier, B. Le Gouill, S. Lederlin, P. Delarue, R. Laurent, Gabrielle[UCL] Bosly, André[UCL] (2009) 14th Annual Meeting of the European-Hematology-Association — Berlin(Germany)
    • Communication
    Rituximab given after high dose therapy and autologous stem cell transplantation induces durable clearance of minimal residual disease in about half of the patients with follicular non Hodgkin's lymphoma: 36 months results of a multicenter open label phase II trial (M39012 trial).
    Morschhauser, F. Recher, C. Milpied, N. Gressin, R Salles, G. Brice, P. Vey, N Haioun, C. Colombat, P Bourhis, JH Rossi, JF Berriot-Varoqueaux, N Bergougnoux, L Bosly, André[UCL] Delsol, G. Attal, M. (2004) 46th Annual Meeting of the American-Society-of-Hematology — San Diego(Ca)
    • Article de périodique
    Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma
    Bachy, E. Houot, R. Morschhauser, F. Sonet, Anne[UCL] Brice, P. Belhadj, K. Cartron, G. Audhuy, B. Fermé, C. Feugier, P. Sebban, C. Delwail, V. Maisonneuve, H. Le Gouill, S. Lefort, S. Brousse, N. Foussard, C. Salles, G. (2013) Haematologica : journal of hematology — Vol. 98, no.7, p. 1107-1114 (2013)
    • Article de périodique
    Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis
    Xerri, L. Bachy, E. Fabiani, B. Canioni, D. Chassagne-Clément, C. Dartigues-Cuilléres, P. Charlotte, F. Brousse, N. Rousselet, M.-C. Foussard, C. Brice, P. Feugier, P. Morschhauser, F. Sonet, Anne[UCL] Olive, D. Salles, G. (2014) Human Pathology — Vol. 45, no.10, p. 2085-2093 (2014)
    • Article de périodique
    Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: Results of the prospective multicenter H96 trial by the GELA/SFGM study group
    Morschhauser, F. Brice, P. Fermé, C. Diviné, M. Salles, G. Bouabdallah, R. Sebban, C. Voillat, L. Casasnovas, O. Stamatoullas, A. Bouabdallah, K. André, Marc Jais, J.-P. Cazals-Hatem, D. Gisselbrecht, C. (2008) Journal of Clinical Oncology — Vol. 26, no.36, p. 5980-5987 (2008)
    • Article de périodique
    ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): Final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial
    Mounier, N. Brice, P. Bologna, S. Briere, J. Gaillard, I. Heczko, M. Gabarre, J. Casasnovas, O. Jaubert, J. Colin, P. Delmer, A. Devidas, A. Bachy, E. Nicolas-Virelizier, E. Aoudjhane, A. Humbrecht, C. André, M.[UCL] Carde, P. Divine, M. Fenaux, P. Coiffier, B. Reman, O. Aoudjhane, M. Blaise, A.M. Bordessoule, D. Bosly, André[UCL] Morschhauser, F. Caillot, D. Gonzalez, H. Lederlin, P. Bouabdallah, R. van Hoof, A. Boulat, O. Bauduer, F. Tournilhac, O. Decaudin, D. Sebban, C. Janvier, M. Kentos, A. Voillat, L. Fabbro, M. Eisenmann, J.C. Martin, C. Christian, B. Ferrant, Augustin[UCL] Salanoubat, C. Varet, B. Bouabdallah, K. de Prijck, B. Levaltier, X. Castaigne, S. Audhuy, B. Frenkiel, N. Rose, C. Fitoussi, O. Orfeuvre, H. Pignon, J.M. (2014) Annals of Oncology — Vol. 25, no.8, p. 1622-1628 (2014)
    • Article de périodique
    Antisense oligodeoxyribonucleotides suppress hematologic cell growth through stepwise release of deoxyribonucleotides
    Vaerman, Jean-Pierre[UCL] Moureau, P. Deldime, F. Lewalle, P. Lammineur, C. Morschhauser, F. Martiat, P. (1997) Blood — Vol. 90, no. 1, p. 331-339 (1997)
    • Article de périodique
    Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: A multicenter study of 51 patients
    Morschhauser, F. Cayuela, JM Martini, S Baruchel, A Rousselot, P. Socie, G. Berthou, P Jouet, JP Straetmans, Nicole[UCL] Sigaux, F. Fenaux, P. Preudhomme, C. (2000) Journal of Clinical Oncology — Vol. 18, no. 4, p. 788-794 (2000)
    • Article de périodique
    Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1b)
    Ketterer, N. Coiffier, B. Thieblemont, C. Fermé, C. Brière, J. Casasnovas, O. Bologna, S. Christian, B. Connerotte, Thierry[UCL] Réher, C. Bordessoule, D. Fruchart, C. Delarue, R. Bonnet, C. Morschhauser, F. Anglaret, B. Soussain, C. Fabiani, B. Tilly, H. Haioun, C. (2013) Annals of Oncology — Vol. 24, no. 4, p. 1032-1037 (2013)
    • Article de périodique
    Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the groupe d'Etude des lymphomes de l'adulte
    Feugier, P Van Hoof, A. Sebban, C. Solal-Celigny, P. Bouabdallah, R. Ferme, C Christian, B. Lepage, E. Tilly, H. Morschhauser, F. Gaulard, P. Salles, G. Bosly, André[UCL] Gisselbrecht, C. Reyes, F. Coiffier, B. (2005) Journal of Clinical Oncology — Vol. 23, no. 18, p. 4117-4126 (2005)